BREAKTHROUGH SIZEON STUDY REVEALED!

Gaspari Nutrition is proud to give you the preliminary results of a nine week 3rd party independent study conducted on SizeOn® Maximum Performance. This was presented this past weekend at the 2010 ISSN Convention in Clearwater, FL. Over the years, owner and IFBB Hall of Famer Rich Gaspari has been vigilant in providing the best supplements money can buy to all the fitness enthusiasts out there and proving that they are both safe and effective. Rich, Team Gaspari, and his Research & Development Team are extremely excited to share the study abstract for all you loyal Gaspari Nutrition customers and supporters out there.

Rich and his team pride themselves on not having to make ridiculous and unsubstantiated claims to win your support. His products are formulated to do what counts which is to help you all become bigger, stronger, or to lose fat mass while increasing lean muscle mass. Isn’t that what should count? Rest assured, Gaspari Nutrition is unwavering in it’s mission to make the absolute best and most innovative products the law allows. The proof is always in the pudding and this is what makes SizeOn Maximum Performance the Ultimate Mass Monster and much more than just a mix of amino acids, creatine, and carbohydrates.

 

Nine Weeks of Supplementation With A Multi-Nutrient Augments Changes in Body Composition, Strength, and Muscle Performance in Resistance Trained Men.

Jennifer Hofheins, MS, RD, LD, Robert Lemieux, MS, and Steven Schmitz, MD, MPH.

The Center for Applied Health Science Research, Division of Sports Nutrition and Exercise Science, Fairlawn, OH 44333, USA

from 2010 International Society of Sports Nutrition Conference and Expo Clearwater Beach, FL, USA. 23-24 June 2010

Objective

The purpose of this study was to compare the effects of supplementation with SizeOn Maximum PerformanceTM (SOmaxP) versus a comparator product (CP) containing an equal amount of creatine (4g) carbohydrate (39g maltodextrin) and protein (7g whey protein hydrolysate) on muscular strength, muscular endurance, and body composition during nine weeks of intense resistance training. Methods: Using a prospective, randomized, double-blind design, 20 healthy men (mean ± SD age, height, weight, % body fat: 22.9 ± 2.6 y, 178.4 ± 5.7 cm, 80.5 ± 6.6 kg, 16.6 ± 4.0 %) were matched for age, body weight, resistance training history, bench press strength, bench press endurance, and percent body fat and then randomly assigned via the ABBA procedure to ingest 1⁄2 scoop (dissolved in 15 oz water) of SOmaxP or CP prior to, and another 1/2 scoop (dissolved in 15 oz water) during resistance exercise. Body composition (DEXA), muscular performance (1-RM bench press and repetitions to failure [RTF: 3 sets x baseline body weight, 60-sec rest between sets]), and clinical blood chemistries were measured at baseline and after nine weeks of supplementation and training. Subjects were required to maintain their normal dietary habits and follow a specific, progressive overload resistance training program (4-d/wk, upper body/lower body split) during the study. An intent-to-treat approach was used and data were analyzed via ANCOVA using baseline values as the covariate. Statistical significance was set a priori at p≤0.05. Results: When adjusted for initial differences, significant between group post-test means were noted in: 1-RM bench press (SOmaxP: 133.3 ± 1.3 kg [19.8% increase] vs. CP: 128.5 ± 1.3 kg [15.3% increase]; p<0.019); lean mass (SOmaxP: 64.1 ± 0.4 kg [2.4% increase] vs. 62.8 ± 0.4 kg [0.27% increase], p<0.049); RTF (SOmaxP: 33.3 ± 1.1 reps [44.8% increase] vs. 27.8 ± 1.1 reps [20.9% increase], p<0.004); and fat mass (SOmaxP: 12.06 ± 0.53 kg [9.8% decrease] vs. 13.90 ± 0.53 kg [4.1% increase], p<0.024). No statistically significant differences in systemic hemodynamics (heart rate, systolic and diastolic blood pressures) or clinical blood chemistries (glucose, BUN-to-creatinine ratio, sodium, potassium, serum protein, albumin-to-globulin ratio, bilirubin, alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, total cholesterol, HDL-cholesterol, triacylglycerol, LDL- cholesterol, CBC) were noted.

Conclusions

These preliminary data indicate that compared to CP, SOmaxP administration augments gains in lean mass, bench press strength, and muscular performance during nine weeks of intense resistance training. Ongoing studies are attempting to confirm these results and clarify the molecular mechanisms by which SOmaxP exerts the observed salutary effects.


To join in on the discussion of this study please join us on Facebook.